Dorsey Wright & Associates Xenon Pharmaceuticals Inc. Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020
SELL
$10.82 - $13.35 $7,292 - $8,997
-674 Closed
0 $0
Q1 2020

Apr 20, 2020
BUY
$8.08 - $17.57 $5,445 - $11,842
674 New
674 $8,000
Q4 2018

Jan 07, 2019
SELL
$5.61 - $12.62 $6,642 - $14,942
-1,184 Closed
0 $0
Q3 2018

Oct 12, 2018
BUY
$9.0 - $14.9 $10,656 - $17,641
1,184 New
1,184 $16,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.41B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email